医学
阿替洛尔
美托洛尔
银屑病
病因学
普萘洛尔
心房颤动
糖尿病
药品
皮肤病科
内科学
心脏病学
药理学
内分泌学
血压
作者
Asha K Rajan,Vedha Pal Jeyamani S,U. Kaviya,Indumathi Somasundaram,R Divya
出处
期刊:International Journal of Pharmacy and Pharmaceutical Sciences
[Innovare Academic Sciences]
日期:2019-01-26
卷期号:: 112-115
被引量:2
标识
DOI:10.22159/ijpps.2019v11i3.29388
摘要
Drug-induced Psoriasis is one among the common etiological factors of Psoriasis reported worldwide. Familiar drugs known to cause psoriasiform eruptions include Anti-malarials, Beta blockers, NSAIDs, Lithium. etc. Certain antihypertensives like ACE inhibitors, diuretics are also documented to have caused psoriatic episodes.
A 57 y old South-Indian male patient with a history of Hypertension, Diabetes Mellitus, Atrial Fibrillation for 4 y; was on antihypertensive therapy for Hypertension and Atrial Fibrillation with proponolol for past 2 y and metoprolol initially. He was presented to the hospital two weeks after switching on to Metoprolol therapy for chief complaints of erythematous scaly lesions especially over both the extremities and paronydrial appearance of nails. Initially, he was on Propranolol therapy which was then shifted to Metoprolol due to an appearance of oral lesions in the mouth. Metoprolol was now discontinued and switched on to Atenolol. After 1-2 w of therapy with Atenolol, the lesions were found to disappear and no recurrence of psoriatic conditions were found.
Proper reviewing of medical history for any allergic reactions and the optimization of drug therapy through Therapeutic Drug Monitoring could be initiated by Clinical Pharmacist in order to avoid such drug-induced flares.
科研通智能强力驱动
Strongly Powered by AbleSci AI